4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

Details for Australian Patent Application No. 2001242501 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Tulp, Martinus T.M.; Tipker, Jacobus; Kruse, Cornelis G.; Lange, Josephus H. M.; Van Vliet, Bernardus J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001242501

PCT Pub. Number WO01/70700

Priority 1014728 23.03.00 NL; 00201032 23.03.00 EP

Filing date 22 March 2001

Wipo publication date 3 October 2001

Acceptance publication date 9 December 2004

International Classifications

C07D 231/06 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 031/415 - 1,2-Diazoles

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 231/08 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 025/04 Drugs for disorders of the nervous system

Event Publications

9 December 2004 Application Accepted

  Published as AU-B-2001242501

7 April 2005 Standard Patent Sealed

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001242502

2001242500